MedPath

Efficacy of probiotics administration in patients with partly controlled asthma: A randomized controlled trial

Phase 2
Conditions
improvement of asthma control symptomsevere asthma exacerbation
Registration Number
TCTR20190818001
Lead Sponsor
Faculty of Medicine Phramongkutklao College of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Enrolling by invitation
Sex
All
Target Recruitment
65
Inclusion Criteria

A.age 18 to 85 years
B.participant with partly asthma based on the Global Initiative for Asthma guidelines 2018. (1-2 of these; in the past 4 weeks, has the patient had : (1) Daytime asthma symptoms more than twice/week (2) any night waking duet to asthma (3) reliever needed for symptoms more than twice/week and (4) any activity limitation due to asthma)

Exclusion Criteria

A.participant with well controlled asthma
B.participant with uncontrolled asthma
C.resting FEV1 less than 1 litre
D.diagnosed immunocompromised host, psychiatric problem, cirrhosis, chronic kidney disease, or autoimmune disease
E.regular use of oral corticosteroids, high-dose multivitamin supplements, or probiotic supplements within 3 months before screening
F.pregnancy or breast feeding
G.being a vegetarian
H.current smoking in 3 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
“combined score” of ACT score based on The Thai National Guideline for Diagnosis and Management 1 months “combined score” of ACT score
Secondary Outcome Measures
NameTimeMethod
percentage change of PFT, absolute esinophil counts, Treg cells and periostin 1 month PFT, absolute esinophil counts, Treg cells and periostin
© Copyright 2025. All Rights Reserved by MedPath